Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Praxis Precision Medicines, Inc. (PRAX) had Consolidated Net Income/Loss of $-73.93M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-73.93M |
|
-- |
|
-- |
|
$78.36M |
|
$-78.36M |
|
$4.42M |
|
$-73.93M |
|
$-73.93M |
|
$-73.93M |
|
$-73.93M |
|
|
Consolidated Net Income/Loss |
$-73.93M |
$-73.93M |
|
$-78.36M |
|
$-79.05M |
|
21.98M |
|
21.98M |
|
$-3.36 |
|
$-3.36 |
|
| Balance Sheet Financials | |
$273.84M |
|
$0.17M |
|
$122.54M |
|
$396.39M |
|
$52.88M |
|
-- |
|
-- |
|
$52.88M |
|
$343.50M |
|
$343.50M |
|
$343.50M |
|
21.17M |
|
| Cash Flow Statement Financials | |
$-172.74M |
|
$17.24M |
|
$89.66M |
|
$215.79M |
|
$149.94M |
|
$-65.84M |
|
$24.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-172.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.52% |
|
-21.52% |
|
-18.65% |
|
-21.52% |
|
$16.23 |
|
$-7.86 |
|
$-7.86 |
|